Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.
Metrics to compare | SANJ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSANJPeersSector | |
---|---|---|---|---|
P/E Ratio | 31.2x | 28.5x | −0.7x | |
PEG Ratio | 1.20 | 0.16 | 0.00 | |
Price/Book | 6.7x | 3.4x | 2.6x | |
Price / LTM Sales | 3.5x | 2.4x | 3.3x | |
Upside (Analyst Target) | - | 18.3% | 39.6% | |
Fair Value Upside | Unlock | 1.0% | 6.0% | Unlock |